News
Consensus recommendations on AMI management during COVID-19
April 28, 2020
The ACC, ACEP, and SCAI recommend a systematic approach for the care of patients with an acute myocardial infarction during the COVID-19 pandemic.
News
Seniors with COVID-19 show unusual symptoms, doctors say
April 27, 2020
The age group most at risk of severe complications may not have fever, insistent cough, or shortness of breath.
News
COVID-19 linked to large vessel stroke in young adults
April 27, 2020
The virus appears to cause disease through a process of blood clotting, according to an expert.
News
FDA reiterates hydroxychloroquine limitations for COVID-19
April 24, 2020
An FDA Safety Communication restates that hydroxychloroquine and chloroquine are only for hospitalized COVID-19 patients who can’t enter a trial.
News
COVID-19: What are the major cardiovascular issues?
April 24, 2020
COVID myocarditis can mimic acute MI or stress cardiomyopathy and will present diagnostic and therapeutic challenges.
News
Angiotensin drugs and COVID-19: More reassuring data
April 24, 2020
Data from one Wuhan hospital show no difference in COVID-19 severity or mortality in patients with hypertension taking ACE inhibitors or ARBs. Other reassuring studies are also emerging.
News
AUGUSTUS: After ACS or PCI, aspirin gives AFib patients scant benefit
April 24, 2020
Adding aspirin to an anticoagulant and P2Y12 inhibitor showed no net benefit, even acutely, suggesting need to target aspirin to highly selected patients.
News
Hydroxychloroquine ineffective for COVID-19, VA study suggests
April 23, 2020
The retrospective study, which included data from 368 men hospitalized with confirmed COVID-19 and treated in VA medical centers, showed an association between HCQ and higher mortality.
News
Signature STEMI sign may be less diagnostic in the COVID-19 age
April 22, 2020
ST-segment elevation, often a ticket to the cath lab, may not indicate STEMI as reliably as before hospitals started to fill with COVID-19 patients, who may have other ST-segment–elevating conditions.
News
ACEI/ARBs linked with survival in hypertensive, Chinese COVID-19 patients
April 22, 2020
A study drawing from 1,128 hypertensive, Chinese patients with COVID-19 suggested that those on an ACEI or ARB had better 28-day survival.